Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Research Methodology
1.3. Research Scope & Assumption
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources & Third-Party Perspectives
1.4.4. Primary Research
1.5. Information Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Data Validation & Publishing
Chapter 2. Contract Development Manufacturing Organization (CDMO) Market Intelligence
2.1. Category Definition
2.2. Category Intelligence
2.2.1. Market Size
2.2.2. Trends
2.2.3. Drivers
2.2.4. Challenges
2.2.5. Regional Outlook
2.3. Technology
2.3.1. Emerging Technology
2.3.2. Best Practices in the Industry
2.4. Regulatory Landscape
2.5. Porter’s Five Forces Analysis
2.5.1. Bargaining power of suppliers
2.5.2. Bargaining power of buyers
2.5.3. Threat of substitutes
2.5.4. Threat of new entrants
2.5.5. Competitive rivalry
Chapter 3. Contract Development Manufacturing Organization (CDMO) Market Supplier Intelligence
3.1. Identification of top 12 service providers
3.1.1. Alcami Corporation
3.1.2. Boehringer Ingelheim International GmbH
3.1.3. Catalent, Inc.
3.1.4. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
3.1.5. Jubilant Pharmova Limited
3.1.6. Merck KGaA
3.1.7. Recipharm AB
3.1.8. Samsung Biologics
3.1.9. Siegfried Holding AG
3.1.10. Syngene International Limited
3.1.11. Thermo Fisher Scientific, Inc.
3.1.12. WuXi Biologics Co., Ltd.
3.2. Contract Development Manufacturing Organization (CDMO) Supply Chain Analysis
3.3. Contract Development Manufacturing Organization (CDMO) Supplier Landscape
3.4. Contract Development Manufacturing Organization (CDMO) Supplier Ranking Methodology
3.4.1. Supplier Operational Capabilities
3.4.1.1. Geographical Service Provision
3.4.1.2. Industries Served
3.4.1.3. Years in Service
3.4.1.4. Employee Strength
3.4.1.5. Revenue Generated
3.4.1.6. Key Clientele
3.4.1.7. Regulatory Certifications
3.4.2. Supplier Functional Capabilities
3.4.2.1. Research
3.4.2.1.1. Pre-Clinical
3.4.2.1.2. Phase I
3.4.2.1.3. Phase II
3.4.2.1.4. Phase III
3.4.2.1.5. Phase IV
3.4.2.2. Development
3.4.2.2.1. Formulation & Drug Product Development
3.4.2.2.2. Cell Line Engineering
3.4.2.2.3. Cell Banking & Characterization
3.4.2.2.4. Others
3.4.2.3. Manufacturing
3.4.2.3.1. DS GMP Manufacturing
3.4.2.3.2. DP GMP Manufacturing
3.4.2.3.3. Others
3.4.2.4. Testing
3.4.2.4.1. Biosafety Testing
3.4.2.4.2. Analytical Testing
3.4.2.4.3. Others
3.4.2.5. Others
3.5. Contract Development Manufacturing Organization (CDMO) Supplier Scoring Criteria
3.6. Contract Development Manufacturing Organization (CDMO) Supplier Positional Matrix (SPM)
3.6.1. Rulers
3.6.2. Challengers
3.6.3. Loungers
3.6.4. Niches
3.7. Contract Development Manufacturing Organization (CDMO) Supplier Market Concentration
3.7.1. Industry structure
3.8. Recommended Service Providers
3.8.1. Supplier 1 with detailed profile
3.8.2. Supplier 2 with detailed profile
3.8.3. Supplier 3 with detailed profile
Chapter 4. Competitive Landscape
4.1. Recent Supplier Developments with Measured Impact
4.1.1. Joint Ventures
4.1.2. Mergers & Acquisitions
4.1.3. Collaborations or Partnerships
4.1.4. Other major developments
4.2. Supply-Demand Analysis
4.2.1. Supply Analysis
4.2.2. Demand Analysis
Chapter 5. Contract Development Manufacturing Organization (CDMO) Pricing and Cost Intelligence
5.1. Total Cost Structure Overview
5.1.1. Manufacturing
5.1.2. Development
5.1.3. Testing and Quality
5.1.4. Additional Services and Materials
5.2. Pricing Intelligence
5.2.1. Factors Influencing the Rates for Contract Development Manufacturing Organization (CDMO)
5.2.1.1. Raw Material Price Fluctuations
5.2.1.2. Labor Cost Variations
5.2.1.3. Transportation and Logistical Expenses
5.2.1.4. Compliance and Quality Control
5.2.2. Pricing Model Analysis
5.2.2.1. Project-based pricing or,
5.2.2.2. Stage-based pricing or,
5.2.2.3. Batch-based pricing or,
5.2.2.4. Batch and Stage-based pricing or,
5.2.2.5. Cost-plus pricing or,
5.2.2.6. Others
5.2.3. Contract Development Manufacturing Organization Rates - Service Provider’s Quotation
Chapter 6. Sourcing Intelligence
6.1. Engagement Model
6.1.1. Fully Outsourcing Model or,
6.1.2. Partial/Hybrid Outsourcing Model or,
6.1.3. In-house Product Development Model or,
6.1.4. Shared Service Model
6.2. Operating Model
6.2.1. Basic Provider or,
6.2.2. Approved Provider or,
6.2.3. Performance-based Model or,
6.2.4. Others
6.3. KPI/SLA Elements
6.4. Negotiation Strategies
6.5. LCC/BCC Sourcing Analysis
6.5.1. China
6.5.2. India
6.5.3. Singapore
6.5.4. France
6.5.5. Germany
6.5.6. Insights on top 2 LCC/BCC Countries
Component wise cost break down for better negotiation for the client, highlights the key cost drivers in the market with future price fluctuation for different materials (e.g.: steel, aluminum, etc.) used in the production process
Offering cost transparency for different products / services procured by the client. A typical report involves 2-3 case scenarios helping clients to select the best suited engagement with the supplier
Determining and forecasting salaries for specific skill set labor to make decision on outsourcing vs in-house.
A typical newsletter study by capturing latest information for specific suppliers related to: M&As, technological innovations, expansion, litigations, bankruptcy etc.